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E-mail address: Helen.Mardon@obs-gyn.ox.ac.uk (Vitronectin is a multi-functional protein found predominantly as a monomer in blood and as an oli-
gomer in the extracellular matrix. We have dissected the minimal regions of vitronectin protein
needed for effective integrin dependent cell adhesion and spreading. A fragment of vitronectin con-
taining the RGD integrin binding site showed similar binding afﬁnity as that of full vitronectin pro-
tein to puriﬁed integrin avb3 but had diminished cell adhesion and spreading function in vivo. We
demonstrate that the oligomeric state of the protein is responsible for this effect. We provide com-
pelling evidence for the involvement of the heparin binding domain of vitronectin in the oligomer-
ization process and show that such oligomerization reinforces the activity of vitronectin in cell
adhesion and spreading.
Structured summary:
MINT-7905703: Vn (uniprotkb:P04004) and Vn (uniprotkb:P04004) bind (MI:0407) by molecular sieving
(MI:0071)
 2010 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Vitronectin, ﬁrst identiﬁed as serum spreading factor, is a multi-
functional glycoprotein found in abundance in the blood and extra-
cellular matrix (ECM). About 30% of the mass of 75 KDa vitronectin
protein is a result of glycosylation [1]. There are a plethora of bind-
ing partners to vitronectin which play an important role in wound
healing, hemostasis, angiogenesis, metastasis, cell adhesion,
spreading and migration [2]. The binding sites for different binding
partners are contained in various domains in vitronectin. A well
studied domain is the somatomedin B domain (SMB), a compact
4 disulphide bond knot at the N-terminus of the protein [3]. This
domain binds to the plasminogen activator inhibitor 1 (PAI-1)
and urokinase receptor (uPAR) and plays an important role in
wound healing [4,5]. Next to the SMB domain is the RGD site which
is an integrin binding region involved in cell adhesion and migra-
tion [6]. The major integrin receptors that recognize this site in
vitronectin are avb3, avb1 and avb5 [7].
An important region and of particular interest in our study is
the heparin binding domain (HBD) on the basic C-terminal region.on behalf of the Federation of Euro
ent of Obstetrics and Gynae-
, The John Radcliffe Hospital,
+44 (0)1865 221001.
H.J. Mardon).Preissner (1991) hypothesised that the basic region is involved in
intra-molecular interaction with the N-terminal acidic region
bringing both the ends together, resulting in several binding sites
left cryptic in the native inactive vitronectin protein [1]. There is
a lack of understanding of the arrangement of different domains
as the molecular structure of native protein has not been resolved.
A recent report showed that the HBD region interacts directly with
the c-loop of b3 subunit in avb3 integrin thereby regulating its
function [8].
Vitronectin is found in a range of oligomeric forms from
monomer to 16-mer [9]. The predominant form of vitronectin
in plasma is the monomeric form and the oligomeric form is
found in the extracellular matrix. The physiological relevance of
such distribution is not clear. There is an increased interest in
the multimerization of vitronectin in particular due to the locali-
sation of vitronectin in the amyloid plaques of brain tissue of pa-
tients with Alzheimer’s disease [10]. The physiological process of
multimerization is yet to be understood. Other proteins binding
to the native form may result in a conformational change which
in turn results in multimerization. It has also been shown that
glycosylation of vitronectin plays a role in multimerization. Step-
wise deglycosylation of vitronectin appears to increase the multi-
merization [11]. Here, we have focussed on the domain required
for multimerization and how it affects the function of cell adhe-
sion and spreading.pean Biochemical Societies.
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2.1. Cloning and expression of human vitronectin fragments
Vitronectin insert excluding the region coding N-terminal
SMB domain was ampliﬁed from full length cDNA clone
(OriGene Technologies Inc., USA) by PCR using KOD DNA poly-
merase (Merck Biosciences Ltd.). This insert was cloned into pRS-
ETa (Invitrogen Ltd., UK) or pGEX6P2 (GE Healthcare UK Ltd.,
UK) vectors using BamHI (50) and EcoRI (30) restriction sites to
generate a construct Vn that codes for 40K–459L of mature pep-
tide (Fig. 1a). An insert coding for 40K–131P containing the inte-
grin binding RGD region and downstream unstructured region
was cloned in the above vectors to generate a construct sVn.
An oligonucleotide corresponding to the HBD (342P–373N) at the
C-terminal region of the vitronectin was inserted as a 30 fusion
to sVn construct between EcoRI and XhoI sites resulting in the
construct sVnHBD. A construct coding only HBD region was gen-
erated by cloning the above HBD coding oligonucleotide into the
pGEX6P2 vector.
The expression vectors were transformed into BL21(DE3)
strain of Escherichia coli for recombinant vitronectin production.
Bacterial culture was induced with 0.1 mM IPTG and incubated
for 5 h at 30 C. NiNTA (Qiagen Ltd., UK) was used to purify
poly-histidine tagged proteins and Glutathione-Sepharose (GE
Healthcare UK Ltd.) was used to purify GST tagged proteins.
Puriﬁcation was performed according to the manufacturer’s
instructions.2.2. Determination of binding afﬁnity of vitronectin fragments to
native avb3 integrin
An ELISA assay was used to determine the binding afﬁnity of
vitronectin fragments to the native avb3 integrin receptor. Integrin
receptor was puriﬁed from human placenta tissue using a protocol
described previously with modiﬁcations [12]. Anti-avb3 integrin
antibody produced from HB11029 clone was used for puriﬁcation
of the integrin. ELISA assay was performed according to the previ-
ously described protocol with modiﬁcations. Doubling dilutions of
2 lM recombinant vitronectin proteins were applied in triplicate.
1:2500 diluted anti-GST antibody (Sigma-Aldrich Company Ltd.,
UK) solution was used as a primary antibody and 1:2500 diluted
anti-mouse-HRP conjugated antibody (Sigma-Aldrich Company
Ltd.) was used as a secondary antibody. The data were ﬁtted for
one site binding using SigmaPlot11 software to obtain the apparent
Kd values.Fig. 1. (a) Recombinant vitronectin constructs: Vn, sVn, and sVnHBD constructs were ge
fusion or pGEX6P2 vector for GST fusion. (b) Puriﬁed vitronectin proteins were subjected
GST-sVn and lane 3 is GST-sVnHBD. M represents the marker lane showing the marker2.3. Cell adhesion assays
Wells of a Maxi-sorp 96 well plate were coated with the desired
protein constructs in triplicates. Fifty microliters of 2 lM recombi-
nant vitronectin protein solution was used for each well. We con-
ﬁrmed that equal amounts of each protein is coated on the wells
using an ELISA assay for the tag (Supplementary Fig. 1). The cell
adhesion assay was performed as described previously using
human endometrial stromal ﬁbroblasts [13].
2.4. Immunostaining
Cell adhesion was performed as described done on round glass
cover slips placed in a four well plate. Immunostaining of the cells
was performed as described previously with minor changes [13].
1:200 diluted anti avb3 integrin antibody (MAB1976, Millipore
UK Ltd., UK) was used to detect integrin and 1:75 diluted anti-
mouse-FITC antibody (Jackson ImmunoResearch Laboratories Inc.,
USA) was used as secondary antibody. 1:75 diluted Texas-red Phal-
loidin (Invitrogen Ltd.) was used for actin staining and DAPI was
used to stain nuclei.
3. Results and discussion
3.1. SDS–PAGE analysis of puriﬁed recombinant vitronectin fragments
Vn, sVn, sVnHBD and heparin binding domain HBD were pro-
duced in modest levels of up to 2–5 mg/L of E. coli culture. All
the proteins were puriﬁed from the cytoplasm without the need
of any denaturation steps. The puriﬁed proteins analysed using
SDS–PAGE (Fig. 1b) showed that the Vn protein had undergone
partial degradation but the sVn and sVnHBD were homogeneous.
The recombinant proteins run slightly higher than the expected
size on SDS–PAGE probably due to acidic nature of the protein (cal-
culated pI for GST tagged Vn = 5.37, sVn = 4.74, sVnHBD = 5.54). In
all our constructs the N-terminal SMB domain was deleted since it
was reported that deletion of SMB domain did not affect cell adhe-
sion and spreading [14]. More over we know from our own mass
spectrometry studies (not shown here) and from earlier studies
that the SMB domain is incorrectly folded in E. coli with wrong
disulphide topology as compared to the plasma vitronectin [3,15].
3.2. Heparin binding domain is required for oligomerization of
vitronectin
The recombinant histidine tag fusion proteins were subjected to
gel-ﬁltration to estimate the approximate molecular size of thenerated by cloning respective vitronectin inserts into pRSETa for poly-histidine tag
to 12% reducing SDS-PAGE to assess the level of purity. Lane 1 is GST-Vn, lane 2 is
weight in KDa.
Fig. 2. Gelﬁltration analysis of vitronectin oligomeric state: Vn protein eluted out in
the void volume of Superdex 200 column indicating that it is a large oligomer. sVn
protein eluted at a retention volume of 16.2 ml corresponding to a monomer size.
Addition of HBD domain to sVn promotes the oligomerization and the resulting
protein eluted at 12.8 ml which is a 200 KDa complex of P10 units.
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that it is a large oligomer which eluted out in the void volume
(Fig. 2). sVn fragment eluted at a retention volume of 16.2 ml indi-
cating that it is a monomer. This has also been conﬁrmed using
multiple angle light scattering experiment. The sVnHBD protein
eluted at a retention volume of 12.8 ml which corresponds to a
molecular weight of around 200 KDa. This molecular weightFig. 3. (a) Light microscope images of cell adhesion: human endometrial stromal fribrob
was hindered on sVn fragment. (b) Cell adhesion on vitronectin fragments: 2 lM solution
wells and the error bar represents the standard deviation.corresponds to an oligomeric number P10 (18 KDa being the
monomer size of sVnHBD). The chromatogram for sVnHBD was
quite broad as seen in the Fig. 2 showing that the protein exists
in several minor intermediate oligomeric forms. Though it is difﬁ-
cult to assign a particular multimer number to the protein, it is
clear that it undergoes multimerization. Vn and sVnHBD contain-
ing the HBD domain formed large oligomers and sVn lacking
HBD did not. The HBD domain had earlier been proposed to be a
probable site for multimerization [9], although, another report
suggested that there is no involvement of HBD in multimerization
in their refolding studies [16]. Our study clearly shows that sVn
protein multimerizes to a large complex when HBD domain is
fused to it and conﬁrms its role in oligomerization.
3.3. Binding afﬁnity of recombinant vitronectin fragments to avb3
integrin
Saturation binding assays were performed to measure the bind-
ing afﬁnity of Vn, sVn and sVnHBD proteins to the native avb3
integrin. The apparent Kd values for Vn, sVn, sVnHBD were
12.3 ± 2.5 nM, 10.9 ± 3.4 nM and 8.2 ± 4.4 nM. These values were
not statistically different showing that integrin binding afﬁnity
was not affected by removal of much of the region outside the
RGD site.
3.4. HBD mediated oligomerization of vitronectin enhances cell
adhesion
The levels of cell adhesion to plasma vitronectin and recombi-
nant Vn were indistinguishable. sVn protein had a considerable
loss of function (Fig. 3a). Only 40% cell adhesion was observed to
sVn compared to Vn (Fig. 3b). A similar construct but with an intactlast cell adhesion on Vn and sVnHBD fragments was similar where as cell adhesion
of each protein was used for coating the plates. Value of each bar is a mean of nine
Fig. 4. Immunostained images of human endometrial stromal ﬁbroblasts: The cells were stained for actin ﬁbres (red) using Texas Red-Phalloidin, nucleus using DAPI. Integrin
avb3 was stained using anti-human integrin av subunit antibody MAB1976Z and antimouse antibody conjugated to FITC as secondary antibody. The cells spreading on
plasma vitronectin, Vn and sVnHBD show clear focal adhesion points and well organised actin ﬁbres. Most of the cells spreading on sVn protein show poorly formed actin
cytoskeleton and diffused integrin staining.
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reported that this construct retained 70% activity of the native
vitronectin. But they achieved this activity at fairly high concentra-
tions of protein (10 lM). We found in a separate study that the
ﬁbronectin cell binding fragment (FnIII9010) forms bilayers at high-
er concentrations [18]. This might also be the case for sVn and the
high concentrations of protein coated onto the well may result in
bilayers mimicking oligomeric state of the vitronectin protein. To
avoid such a possibility we used a relatively low concentration of
vitronectin fragments with the aim of retaining similar physical
properties both in solution and attached to the well. Surprisingly,
95% cell adhesion was observed to sVnHBD fragment compared
to Vn (Fig. 3b) showing that the HBD domain enhances sVn func-
tion. There was no signiﬁcant difference in cell adhesion compared
to the HBD domain alone.
3.5. Cell morphology of spreading cells
The immunostained images showed that there was no distin-
guishable difference in the morphology of spreading among the
cells spread on plasma vitronectin, Vn and sVnHBD proteins. These
cells had a well organised actin cytoskeleton (Fig. 4). Staining for
the integrin avb3 showed prominent focal adhesions co-localized
with actin at the cell membrane. Most of the cells attached to
sVn protein had a poorly formed actin cytoskeleton (Supplemen-
tary Fig 2). There were very few focal adhesions. This result is con-
sistent with an earlier report which showed that the C-terminalheparin binding site is necessary for cytoskeletal organisation
and migration of endothelial cells though this study did not say
why [19].
Taken together, our data to show that the RGD region itself is
sufﬁcient for integrin binding but not for its full function in cell
adhesion and spreading. Our data conﬁrm that the HBD is involved
in the multimerization process of vitronectin and that the sVnHBD
construct represents the minimal domain requirement for integrin
dependent cell adhesion and spreading function of vitronectin.
Sano et al. (2007) showed that the larger the multimer of vitronec-
tin the more efﬁciently it binds to collagen [11]. It has also been
shown that stiffness of ECM is required for activation of integrin
a5b1 [20]. In addition, the oligomeric form has been demonstrated
to increase the adhesion strength of the ECM protein [21]. We pro-
pose that oligomeric vitronectin forms strong bonds with collagen
creating a stiff ECM, which allows formation of stronger adhesion
to integrin and a well organized actin cytoskeleton.Acknowledgement
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